EZH2 and neoplasm: In conjunction with additional tumor suppressors, the PRC2 subunits EED and SUZ12 (but not EZH2) are mutated in 85% of malignant peripheral nerve sheath tumors (MPNST) that develop in patients with NF1 mutations (140).